How tirzepatide affects alcohol processing
Part of Hormones & metabolism clinical trials.
This study looks at how the medicine tirzepatide (often used for diabetes or weight loss) affects the way your body processes alcohol. It may help understand if taking this medicine changes how alcohol affects you, which could lead to better guidance for people who drink while using it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 21 and 55 years old.
- You must have a body mass index (BMI) between 30 and 45.
- You must be currently taking the branded medication tirzepatide (e.g., Mounjaro, Zepbound) at a steady dose for at least 4 weeks.
- You must regularly drink alcohol.
- You must be in good general health, with no major medical conditions, and not have certain past or present health issues like pancreatitis or certain thyroid cancers.
- You must be able to speak English, have a valid driver's license with at least 2 years of driving experience, and be willing to give written consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a medication called tirzepatide (a once-weekly injection) can help people reduce their alcohol consumption. It is for people who drink heavily, have a high BMI, and are actively seeking help to drink less.
This study tests if the drug tirzepatide can improve muscle and blood vessel health in older adults with obesity. You may be eligible if you are 50 or older, have a BMI between 30 and 40, and do not have diabetes.
This trial tests if tirzepatide, a medication that helps with weight and blood sugar, can improve liver health in people with alcohol use disorder who also have fatty liver disease. It aims to reduce liver fat and related risks.
This trial tests if tirzepatide, a once-weekly injection, can help reduce heavy drinking in people who have both schizophrenia and alcohol use disorder. If you struggle with alcohol and have stable schizophrenia, this study may offer a new treatment option.
This trial tests if tirzepatide, a medication that helps with appetite and blood sugar, can help people with alcohol use disorder drink less or stop drinking. You would visit the clinic regularly and receive the drug or a placebo.
This trial tests a medication called tirzepatide (which can help with weight loss) combined with talking therapy (cognitive-behavioural therapy) to help people reduce or stop drinking alcohol while also losing weight. It may be a good fit if you're overweight and want to change your drinking habits.
Hear when a new GLP-1 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.